More than half of the p53-abn endometrioid tumors were diagnosed at an early stage, in contrast to the non-endometrioid p53-abn subtypes, which mainly were diagnosed at an advanced FIGO stage IV (Fig. 1d). This evidence concerns the gene TP53 and endometrioid tumor.